Eribulin Baxter

Eribulin Mesylate is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often administered intravenously.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer and liposarcoma. It is a type of chemotherapy drug that targets rapidly dividing cancer cells. Patients often wonder, 'What is Eribulin Mesylate used for?' It is typically prescribed for advanced stages of cancer when other treatments have not been effective.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients also experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary widely among individuals.

Eribulin Mesylate should be handled with care, as it is a potent chemotherapy agent. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women and individuals with certain medical conditions should consult their doctor before use.

Eribulin Mesylate may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin Mesylate.